The rising prevalence in GLP-1 agonists for weight management has sparked a question about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 therapies were solely available in pill form, but the emergence of skin applications offers a different choice . Transdermal systems might suit individuals experiencing issues with oral m